Earnings Reportpositive

Earnings Report

Other upcoming events for OGN

Phase 3 ReadoutPhase 3 Topline: A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
Phase 3 ReadoutPhase 3 Topline: A Randomized, Double-Blind, Vehicle-Controlled (Period 1) and Open-Label (Period 2) Phase 3 Study to

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Earnings Report — OGN Earnings Report | BioSniper